Citations (95)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Alex Xenopoulos & Priyabrata Pattnaik. (2014) Production and purification of plasmid DNA vaccines: is there scope for further innovation?. Expert Review of Vaccines 13:12, pages 1537-1551.
Read now
Read now
Anca Reschner, Sophie Scohy, Gaëlle Vandermeulen, Marc Daukandt, Céline Jacques, Benjamin Michel, Hans Nauwynck, Florence Xhonneux, Véronique Préat, Alain Vanderplasschen & Cédric Szpirer. (2013) Use of Staby® technology for development and production of DNA vaccines free of antibiotic resistance gene. Human Vaccines & Immunotherapeutics 9:10, pages 2203-2210.
Read now
Read now
Jessica C. Dong & Gary P. Kobinger. (2013) Hypothesis driven development of new adjuvants. Human Vaccines & Immunotherapeutics 9:4, pages 808-811.
Read now
Read now
Dong Liu, Jing Wang & Zhong-Xiang Niu. (2010) Contribution of Chinese Pekin duck complement component C3d-P29 repeats to enhancement of Th2-biased immune responses against NDV F gene induced by DNA immunization. Immunopharmacology and Immunotoxicology 32:2, pages 297-306.
Read now
Read now
Sylvia van Drunen Littel-van den Hurk & D Hannaman. (2010) Electroporation for DNA immunization: clinical application. Expert Review of Vaccines 9:5, pages 503-517.
Read now
Read now
Alain Luxembourg, Claire F Evans & Drew Hannaman. (2007) Electroporation-based DNA immunisation: translation to the clinic. Expert Opinion on Biological Therapy 7:11, pages 1647-1664.
Read now
Read now
Articles from other publishers (89)
Garima Sahu, Priyanka Kumari & Amit K. Goyal. 2024. Molecular Pharmaceutics and Nano Drug Delivery. Molecular Pharmaceutics and Nano Drug Delivery
15
62
.
Se Eun Kim, So Hee Park, Woo-Jung Park, Gayeong Kim, Seo Yeon Kim, Hyeran Won, Yun-Ho Hwang, Heeji Lim, Hyeon Guk Kim, You-Jin Kim, Dokeun Kim & Jung-Ah Lee. (2023) Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants. PLOS ONE 18:12, pages e0295594.
Crossref
Crossref
Sthefany Pagliari, Barbara Dema, Alexandra Sanchez-Martinez, Gerardo Montalvo Zurbia-Flores & Christine S. Rollier. (2023) DNA Vaccines: History, Molecular Mechanisms and Future Perspectives. Journal of Molecular Biology 435:23, pages 168297.
Crossref
Crossref
Tong Chen, Zhe Ding, Jiaming Lan & Gary Wong. (2023) Advances and perspectives in the development of vaccines against highly pathogenic bunyaviruses. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Roghayyeh Baghban, Abdolmajid Ghasemian & Shirin Mahmoodi. (2023) Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19). Archives of Microbiology 205:4.
Crossref
Crossref
Chao Chen, Xuhong Zhao, Zhigao An, Muhammad Jamil Ahmad, Kaifeng Niu, Xinxin Zhang, Pei Nie, Jiaomei Tang, Aixin Liang & Liguo Yang. (2023) Nasal immunization with AMH-INH-RFRP DNA vaccine for improving follicle development and fertility in buffaloes. Frontiers in Endocrinology 14.
Crossref
Crossref
Sunny Kumar, Malini Basu, Pratyasha Ghosh, Aafreen Ansari & Mrinal K. Ghosh. (2022) COVID‐19: Clinical status of vaccine development to date. British Journal of Clinical Pharmacology 89:1, pages 114-149.
Crossref
Crossref
Fernanda Alvarenga Lima Barroso, Luís Cláudio Lima de Jesus, Tales Fernando da Silva, Andria dos Santos Freitas, Monique Ferrary Américo, Lucas Jorge da Silva Fernandes, Rafael de Assis Gloria, Gabriela Munis Campos, Rodrigo Dias de Oliveira Carvalho, Túlio Marcos Santos, Juliana Guimarães Laguna & Vasco Ariston de Carvalho Azevedo. 2023. Lactic Acid Bacteria as Cell Factories. Lactic Acid Bacteria as Cell Factories
1
16
.
Andrea Marsella, Francesco Pascoli, Tobia Pretto, Alessandra Buratin, Lorena Biasini, Miriam Abbadi, Luana Cortinovis, Paola Berto, Amedeo Manfrin, Marco Vanelli, Simona Perulli, Jesper S. Rasmussen, Dagoberto Sepúlveda, Niccolò Vendramin, Niels Lorenzen & Anna Toffan. (2022) Efficacy of DNA Vaccines in Protecting Rainbow Trout against VHS and IHN under Intensive Farming Conditions. Vaccines 10:12, pages 2062.
Crossref
Crossref
Chao Chen, Zichao Zhou, Kaifeng Niu, Chao Du, Aixin Liang & Liguo Yang. (2022) Efficacy and Safety of Nasal Immunisation with Somatostatin DNA Vaccine for Growth Promotion in Fattening Pigs. Animals 12:22, pages 3072.
Crossref
Crossref
Isabel Acosta-Coley, Leonor Cervantes-Ceballos, Lesly Tejeda-Benítez, Lucellys Sierra-Márquez, María Cabarcas-Montalvo, María García-Espiñeira, Wilfrido Coronell-Rodríguez & Bárbara Arroyo-Salgado. (2022) Vaccines platforms and COVID-19: what you need to know. Tropical Diseases, Travel Medicine and Vaccines 8:1.
Crossref
Crossref
Shalini Iyer, Rajesh Yadav, Smriti Agarwal, Shashank Tripathi & Rachit Agarwal. (2022) Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases. Clinical Microbiology Reviews 35:1.
Crossref
Crossref
Richard Stebbings, Gillian Armour, Vivian Pettis & Joanne Goodman. (2022) AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice. Vaccine 40:2, pages 192-195.
Crossref
Crossref
Xue-Liang Peng, Ji-Si-Yu Cheng, Hai-Lun Gong, Meng-Di Yuan, Xiao-Hong Zhao, Zibiao Li & Dai-Xu Wei. (2021) Advances in the design and development of SARS-CoV-2 vaccines. Military Medical Research 8:1.
Crossref
Crossref
Xiaoyue Yang, Jiansheng Fan, Yue Wu, Zhiming Ma, Jin Huang, Ying Zhang, Zhan Zhou, Fan Mo, Xuerong Liu, Hong Yuan, Yingchun Xu, Liqiang Pan & Shuqing Chen. (2021) Synthetic multiepitope neoantigen DNA vaccine for personalized cancer immunotherapy. Nanomedicine: Nanotechnology, Biology and Medicine 37, pages 102443.
Crossref
Crossref
Emmeline L. Blanchard, Daryll Vanover, Swapnil Subhash Bawage, Pooja Munnilal Tiwari, Laura Rotolo, Jared Beyersdorf, Hannah E. Peck, Nicholas C. Bruno, Robert Hincapie, Frank Michel, Jackelyn Murray, Heena Sadhwani, Bob Vanderheyden, M. G. Finn, Margo A. Brinton, Eric R. Lafontaine, Robert J. Hogan, Chiara Zurla & Philip J. Santangelo. (2021) Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents. Nature Biotechnology 39:6, pages 717-726.
Crossref
Crossref
Niall McMullan. 2021. Molecular Biology and Biotechnology. Molecular Biology and Biotechnology
440
488
.
Flavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini, Patrizia Leone, Andrea Giovannelli, Eleonora Olivetta & Maurizio Federico. (2021) Long-Term Antitumor CD8+ T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles. Cancers 13:9, pages 2263.
Crossref
Crossref
Virgil Schijns, Dragomira Majhen, Peter van der Ley, Aneesh Thakur, Artur Summerfield, Rita Berisio, Cristina Nativi, Alberto Fernández-Tejada, Carmen Alvarez-Dominguez, Sveinbjörn Gizurarson, Alla Zamyatina, Antonio Molinaro, Camillo Rosano, Žiga Jakopin, Ihsan Gursel & Siobhán McClean. (2021) Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation. Pharmaceutics 13:4, pages 501.
Crossref
Crossref
Kang-Hyun Han, Min Seong Jang, Hyoung-Yun Han, Wan-Jung Im, Kyung Jin Jung, Ki Seok Park, Donghoon Choi, Hye Gwang Jeong, Sang Kyum Kim & Kyoung-Sik Moon. (2021) Preclinical safety assessment of a therapeutic human papillomavirus DNA vaccine combined with intravaginal interleukin-7 fused with hybrid Fc in female rats. Toxicology and Applied Pharmacology 413, pages 115406.
Crossref
Crossref
Zuzana Strizova, Jitka Smetanova, Jirina Bartunkova & Tomas Milota. (2021) Principles and Challenges in anti-COVID-19 Vaccine Development. International Archives of Allergy and Immunology 182:4, pages 339-349.
Crossref
Crossref
Megha Kadam Bedekar & Sajal Kole. 2021. Advances in Fisheries Biotechnology. Advances in Fisheries Biotechnology
289
336
.
Shilu Mathew, Muhammed Faheem, Neeraja A. Hassain, Fatiha M. Benslimane, Asmaa A. Al Thani, Hassan Zaraket & Hadi M. Yassine. (2020) Platforms Exploited for SARS-CoV-2 Vaccine Development. Vaccines 9:1, pages 11.
Crossref
Crossref
Yen-Der Li, Wei-Yu Chi, Jun-Han Su, Louise Ferrall, Chien-Fu Hung & T.-C. Wu. (2020) Coronavirus vaccine development: from SARS and MERS to COVID-19. Journal of Biomedical Science 27:1.
Crossref
Crossref
Aubrey M. Demchuk & Trushar R. Patel. (2020) The biomedical and bioengineering potential of protein nanocompartments. Biotechnology Advances 41, pages 107547.
Crossref
Crossref
Irina Petrushina, Armine Hovakimyan, Indira S. Harahap-Carrillo, Hayk Davtyan, Tatevik Antonyan, Gor Chailyan, Konstantin Kazarian, Maxim Antonenko, Amandine Jullienne, Mary M. Hamer, Andre Obenaus, Olga King, Karen Zagorski, Mathew Blurton-Jones, David H. Cribbs, Harry Lander, Anahit Ghochikyan & Michael G. Agadjanyan. (2020) Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials. Neurobiology of Disease 139, pages 104823.
Crossref
Crossref
Chiara Chiozzini, Francesco Manfredi, Claudia Arenaccio, Flavia Ferrantelli, Patrizia Leone & Maurizio Federico. (2020) N-Terminal Fatty Acids of NEFMUT Are Required for the CD8+ T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles. Vaccines 8:2, pages 243.
Crossref
Crossref
Hongping Deng, Christian J. Konopka, Tzu-Wen L. Cross, Kelly S. Swanson, Lawrence W. Dobrucki & Andrew M. Smith. (2019) Multimodal Nanocarrier Probes Reveal Superior Biodistribution Quantification by Isotopic Analysis over Fluorescence. ACS Nano 14:1, pages 509-523.
Crossref
Crossref
Y.-D. Li, W.-Y. Chi, J.-H. Su, L. Ferrall, C.-F. Hung & T.-C. Wu. (2020) CORONAVIRUS VACCINE DEVELOPMENT: FROM SARS AND MERS TO COVID-19 (RUSSIAN TRANSLATION). Juvenis Scientia 6:6, pages 41-80.
Crossref
Crossref
Patrick Tjok Joe, Ioanna Christopoulou, Lien van Hoecke, Bert Schepens, Tine Ysenbaert, Carlo Heirman, Kris Thielemans, Xavier Saelens & Joeri L. Aerts. (2019) Intranodal administration of mRNA encoding nucleoprotein provides cross-strain immunity against influenza in mice. Journal of Translational Medicine 17:1.
Crossref
Crossref
Catherine Collins, Niels Lorenzen & Bertrand Collet. (2019) DNA vaccination for finfish aquaculture. Fish & Shellfish Immunology 85, pages 106-125.
Crossref
Crossref
Nevena Arsenović-Ranin. (2019) New vaccines on the horizon. Arhiv za farmaciju 69:6, pages 385-405.
Crossref
Crossref
Iva I. IvanovaNikolina M. MihaylovaIliyan K. ManoylovDimitra MakatsoriStephan LolovMaria H. NikolovaAvgi MamalakiJozsef PrechlAndrey I. Tchorbanov. (2018)
Targeting of Influenza Viral Epitopes to Antigen-Presenting Cells by Genetically Engineered Chimeric Molecules in a Humanized NOD
SCID
Gamma Transfer Model
. Human Gene Therapy 29:9, pages 1056-1070.
Crossref
Crossref
Grace Cole, Nicholas J. Dunne & Helen O. McCarthy. 2018. Microneedles for Drug and Vaccine Delivery and Patient Monitoring. Microneedles for Drug and Vaccine Delivery and Patient Monitoring
129
175
.
Lesley C. Dupuy, Michelle J. Richards, Brian D. Livingston, Drew Hannaman & Connie S. Schmaljohn. (2018) A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges. Journal of Immunology Research 2018, pages 1-15.
Crossref
Crossref
Osmarie Martínez, Ariana Bravo Cruz, Saritza Santos, Maite Ramírez, Eric Miranda, Joanna Shisler & Miguel Otero. (2017) Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge. Vaccine 35:44, pages 6007-6014.
Crossref
Crossref
S.H.T. Jorritsma, E.J. Gowans, B. Grubor-Bauk & D.K. Wijesundara. (2016) Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines. Vaccine 34:46, pages 5488-5494.
Crossref
Crossref
Paul Spearman, Mark Mulligan, Evan J. Anderson, Andi L. Shane, Kathy Stephens, Theda Gibson, Brooke Hartwell, Drew Hannaman, Nora L. Watson & Karnail Singh. (2016) A phase 1, randomized, controlled dose-escalation study of EP-1300 polyepitope DNA vaccine against Plasmodium falciparum malaria administered via electroporation. Vaccine 34:46, pages 5571-5578.
Crossref
Crossref
Angeliki Tiptiri-Kourpeti, Katerina Spyridopoulou, Aglaia Pappa & Katerina Chlichlia. (2016) DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy. Pharmacology & Therapeutics 165, pages 32-49.
Crossref
Crossref
Cláudia P.A. Alves, Michaela Šimčíková, Liliana Brito, Gabriel A. Monteiro & Duarte Miguel F. Prazeres. (2016) Development of a nicking endonuclease-assisted method for the purification of minicircles. Journal of Chromatography A 1443, pages 136-144.
Crossref
Crossref
Ana Sara Cordeiro, María José Alonso & María de la Fuente. (2015) Nanoengineering of vaccines using natural polysaccharides. Biotechnology Advances 33:6, pages 1279-1293.
Crossref
Crossref
Spela Kos, Natasa Tesic, Urska Kamensek, Tanja Blagus, Maja Cemazar, Simona Kranjc, Jaka Lavrencak & Gregor Sersa. (2015) Improved Specificity of Gene Electrotransfer to Skin Using pDNA Under the Control of Collagen Tissue-Specific Promoter. The Journal of Membrane Biology 248:5, pages 919-928.
Crossref
Crossref
Duarte Miguel F. Prazeres & Gabriel A. Monteiro. 2015. Plasmids. Plasmids
669
688
.
W. M. Bogers, H. Oostermeijer, P. Mooij, G. Koopman, E. J. Verschoor, D. Davis, J. B. Ulmer, L. A. Brito, Y. Cu, K. Banerjee, G. R. Otten, B. Burke, A. Dey, J. L. Heeney, X. Shen, G. D. Tomaras, C. Labranche, D. C. Montefiori, H.-X. Liao, B. Haynes, A. J. Geall & S. W. Barnett. (2014) Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion. Journal of Infectious Diseases 211:6, pages 947-955.
Crossref
Crossref
Duarte Miguel F. Prazeres & Gabriel A. Monteiro. (2014) Plasmid Biopharmaceuticals. Microbiology Spectrum 2:6.
Crossref
Crossref
Kenneth McCullough, Panagiota Milona, Lisa Thomann-Harwood, Thomas Démoulins, Pavlos Englezou, Rolf Suter & Nicolas Ruggli. (2014) Self-Amplifying Replicon RNA Vaccine Delivery to Dendritic Cells by Synthetic Nanoparticles. Vaccines 2:4, pages 735-754.
Crossref
Crossref
Nikola S. Kerekov, Iva I. Ivanova, Nikolina M. Mihaylova, Maria Nikolova, Jozsef Prechl & Andrey I. Tchorbanov. (2014) Built-in adjuvanticity of genetically and protein-engineered chimeric molecules for targeting of influenza A peptide epitopes. Immunologic Research 60:1, pages 23-34.
Crossref
Crossref
Michael C. FlickingerJames N. Warnock & Mohamed Al‐Rubeai. 2009. Encyclopedia of Industrial Biotechnology. Encyclopedia of Industrial Biotechnology
1
16
.
Luís Raiado-Pereira, Jonathan De La Vega, D. Miguel F. Prazeres & Marília Mateus. (2014) Development of a phenyl membrane chromatography-based process yielding pharmaceutical grade plasmid deoxyribonucleic acid for mammalian cells transfection. Journal of Chromatography A 1337, pages 67-74.
Crossref
Crossref
Sandhya Vasan. 2014. Electroporation Protocols. Electroporation Protocols
291
307
.
Liangbiao George Hu & David W. Clarke. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
26
.
Jonathan De La Vega, Bas Ter Braak, Adriano R. Azzoni, Gabriel A. Monteiro & Duarte Miguel F. Prazeres. (2013) Impact of Plasmid Quality on Lipoplex-Mediated Transfection. Journal of Pharmaceutical Sciences 102:11, pages 3932-3941.
Crossref
Crossref
Wen-Hsuan W. Lin, Adrian Vilalta, Robert J. Adams, Alain Rolland, Sean M. Sullivan & Diane E. Griffin. (2013) Vaxfectin Adjuvant Improves Antibody Responses of Juvenile Rhesus Macaques to a DNA Vaccine Encoding the Measles Virus Hemagglutinin and Fusion Proteins. Journal of Virology 87:12, pages 6560-6568.
Crossref
Crossref
Robert V. House. 2013. Nonclinical Safety Assessment. Nonclinical Safety Assessment
381
392
.
Barbara Langer, Matthias Renner, Jürgen Scherer, Silke Schüle & Klaus Cichutek. 2013. Biolistic DNA Delivery. Biolistic DNA Delivery
371
388
.
Koen OosterhuisEsil AleydKim VrijlandTon N. SchumacherJohn B. Haanen. (2012) Rational Design of DNA Vaccines for the Induction of Human Papillomavirus Type 16 E6- and E7-Specific Cytotoxic T-Cell Responses. Human Gene Therapy 23:12, pages 1301-1312.
Crossref
Crossref
F.E. Henken, K. Oosterhuis, P. Öhlschläger, L. Bosch, E. Hooijberg, J.B.A.G. Haanen & R.D.M. Steenbergen. (2012) Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7. Vaccine 30:28, pages 4259-4266.
Crossref
Crossref
Niall McMullan. 2012. Molecular and Cellular Therapeutics. Molecular and Cellular Therapeutics
286
303
.
Sandra Iurescia, Daniela Fioretti, Vito Michele Fazio & Monica Rinaldi. (2012) Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: A biotech's challenge. Biotechnology Advances 30:1, pages 372-383.
Crossref
Crossref
A. Gabriela Gomes, Ana M. Azevedo, M. Raquel Aires-Barros & D. Miguel F. Prazeres. (2011) Studies on the adsorption of cell impurities from plasmid-containing lysates to phenyl boronic acid chromatographic beads. Journal of Chromatography A 1218:48, pages 8629-8637.
Crossref
Crossref
Tiruvayipati Suma AvasthiNiyaz Ahmed. (2011)
Helicobacter pylori
and Type 1 Diabetes Mellitus: Possibility of Modifying Chronic Disease Susceptibility with Vaccinomics at the Anvil
. OMICS: A Journal of Integrative Biology 15:9, pages 589-596.
Crossref
Crossref
Duarte Miguel F. Prazeres. 2011. Plasmid Biopharmaceuticals. Plasmid Biopharmaceuticals
211
242
.
Sandhya Vasan, Arlene Hurley, Sarah J. Schlesinger, Drew Hannaman, David F. Gardiner, Daniel P. Dugin, Mar Boente-Carrera, Roselle Vittorino, Marina Caskey, Johanne Andersen, Yaoxing Huang, Josephine H. Cox, Tony Tarragona-Fiol, Dilbinder K. Gill, Hannah Cheeseman, Lorna Clark, Len Dally, Carol Smith, Claudia Schmidt, Harriet H. Park, Jakub T. Kopycinski, Jill Gilmour, Patricia Fast, Robert Bernard & David D. Ho. (2011) In Vivo Electroporation Enhances the Immunogenicity
of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers. PLoS ONE 6:5, pages e19252.
Crossref
Crossref
Lidia M. D. Goncalves, Ana Cadete, Lara Figueiredo, Cecilia C. R. Calado & Antonio J. Almeida. (2011) Biodegradable nanoparticles of alginate and chitosan as non-viral DNA oral delivery system. Biodegradable nanoparticles of alginate and chitosan as non-viral DNA oral delivery system.
Karen E. Dolter, Claire F. Evans, Barry Ellefsen, Juwan Song, Mar Boente-Carrera, Roselle Vittorino, Talia J. Rosenberg, Drew Hannaman & Sandhya Vasan. (2011) Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation. Vaccine 29:4, pages 795-803.
Crossref
Crossref
James N. Warnock, Claire Daigre & Mohamed Al-Rubeai. 2011. Viral Vectors for Gene Therapy. Viral Vectors for Gene Therapy
1
25
.
Haiyan Chang, Chaoyang Huang, Jian Wu, Fang Fang, Wenjie Zhang, Fuyan Wang & Ze Chen. (2010) A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus. Virology Journal 7:1.
Crossref
Crossref
Andreas Bråve, Lindvi Gudmundsdotter, Eric Sandström, B. Kristian Haller, David Hallengärd, Anna-Karin Maltais, Alan D. King, Richard R. Stout, Pontus Blomberg, Urban Höglund, Bo Hejdeman, Gunnel Biberfeld & Britta Wahren. (2010) Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation. Vaccine 28:51, pages 8203-8209.
Crossref
Crossref
Sarah Gould & Raymond Oomen. 2010. Predictive Toxicology in Drug Safety. Predictive Toxicology in Drug Safety
344
370
.
Wangxue Chen, Rhonda KuoLee & Hongbin Yan. (2010) The potential of 3′,5′-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant. Vaccine 28:18, pages 3080-3085.
Crossref
Crossref
Neelja Singhal, Deepa Bisht & Beenu Joshi. (2010) Immunoprophylaxis of Tuberculosis: An Update of Emerging Trends. Archivum Immunologiae et Therapiae Experimentalis 58:2, pages 97-106.
Crossref
Crossref
Shayne Cox GadA. Marguerite Dempster & Richard Haworth. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Georg Eschenburg, Alexander Stermann, Robert Preissner, Hellmuth-Alexander Meyer & Holger N. Lode. (2010) DNA Vaccination: Using the Patient's Immune System to Overcome Cancer. Clinical and Developmental Immunology 2010, pages 1-14.
Crossref
Crossref
Brian D. Livingston, Stephen F. Little, Alain Luxembourg, Barry Ellefsen & Drew Hannaman. (2010) Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques. Vaccine 28:4, pages 1056-1061.
Crossref
Crossref
K. Oosterhuis, J. H. van den Berg, T. N. Schumacher & J. B. A. G. Haanen. 2012. Intradermal Immunization. Intradermal Immunization
221
250
.
Marlen Castellanos, Zurina Cinza, Zaily Dorta, Gloria Veliz, Héctor Vega, Irma Lorenzo, Sergio Ojeda, Santiago Dueñas-Carrera, Liz Alvarez-Lajonchere, Gillian MartÃnez, Elena Ferrer, Miladys Limonta, Marbelis Linares, Odalis Ruiz, Boris Acevedo, Dinorah Torres, Gabriel Márquez, Luis Herrera & Enrique Arús. (2010) Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti-hepatitis B vaccination. The Journal of Gene Medicine 12:1, pages 107-116.
Crossref
Crossref
Karen Colbjørn Larsen, Alexandra J. Spencer, Anna L. Goodman, Ashley Gilchrist, Julie Furze, Christine S. Rollier, Endre Kiss-Toth, Sarah C. Gilbert, Migena Bregu, Elizabeth J. Soilleux, Adrian V.S. Hill & David H. Wyllie. (2009) Expression of tak1 and tram induces synergistic pro-inflammatory signalling and adjuvants DNA vaccines. Vaccine 27:41, pages 5589-5598.
Crossref
Crossref
Sarah M. McWhirter, Roman Barbalat, Kathryn M. Monroe, Mary F. Fontana, Mamoru Hyodo, Nathalie T. Joncker, Ken J. Ishii, Shizuo Akira, Marco Colonna, Zhijian J. Chen, Katherine A. Fitzgerald, Yoshihiro Hayakawa & Russell E. Vance. (2009) A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP. Journal of Experimental Medicine 206:9, pages 1899-1911.
Crossref
Crossref
G D Victora, A Socorro-Silva, E C Volsi, K Abdallah, F D Lima, R B Smith, R A Moyses, C R Zárate-Bladés, P Michaluart, C L Silva, J Kalil & V Coelho. (2009) Immune response to vaccination with DNA-hsp65 in a phase I clinical trial with head and neck cancer patients. Cancer Gene Therapy 16:7, pages 598-608.
Crossref
Crossref
James A. Williams, Aaron E. Carnes & Clague P. Hodgson. (2009) Plasmid DNA vaccine vector design: Impact on efficacy, safety and upstream production. Biotechnology Advances 27:4, pages 353-370.
Crossref
Crossref
Rogério S Rosada, Lucimara Gaziola de la Torre, Fabiani G Frantz, Ana PF Trombone, Carlos R Zárate-Bladés, Denise M Fonseca, Patrícia RM Souza, Izaíra T Brandão, Ana P Masson, Édson G Soares, Simone G Ramos, Lúcia H Faccioli, Célio L Silva, Maria HA Santana & Arlete AM Coelho-Castelo. (2008) Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes. BMC Immunology 9:1.
Crossref
Crossref
Chien-Hsiung Pan, Gretchen S. Jimenez, Nitya Nair, Qun Wei, Robert J. Adams, Fernando P. Polack, Alain Rolland, Adrián Vilalta & Diane E. Griffin. (2008) Use of Vaxfectin Adjuvant with DNA Vaccine Encoding the Measles Virus Hemagglutinin and Fusion Proteins Protects Juvenile and Infant Rhesus Macaques against Measles Virus. Clinical and Vaccine Immunology 15:8, pages 1214-1221.
Crossref
Crossref
Juergen Mairhofer & Reingard Grabherr. (2008) Rational Vector Design for Efficient Non-viral Gene Delivery: Challenges Facing the Use of Plasmid DNA. Molecular Biotechnology 39:2, pages 97-104.
Crossref
Crossref
Karina RamirezEileen M. BarryJeffrey UlmerRichard StoutJames SzaboScott ManetzMyron M. LevineMarcela F. Pasetti. (2008) Preclinical Safety and Biodistribution of Sindbis Virus Measles DNA Vaccines Administered as a Single Dose or Followed by Live Attenuated Measles Vaccine in a Heterologous Prime–Boost Regimen. Human Gene Therapy 19:5, pages 522-531.
Crossref
Crossref
Germán H. Fontanella, Kristof De Vusser, Wouter Laroy, Lucas Daurelio, Ana Lía Nocito, Silvia Revelli & Roland Contreras. (2008) Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: A vaccine candidate. Vaccine 26:19, pages 2322-2334.
Crossref
Crossref
Yaoxing Huang, Zhiwei Chen, Wenyong Zhang, Deborah Gurner, Yang Song, David F Gardiner & David D Ho. (2008) Design, Construction, and Characterization of a Dual-Promoter Multigenic DNA Vaccine Directed Against an HIV-1 Subtype C/B′ Recombinant. JAIDS Journal of Acquired Immune Deficiency Syndromes 47:4, pages 403-411.
Crossref
Crossref
Kanishtha Agarwal & Shvetank Agarwal. (2008) Helicobacter pylori Vaccine: From Past to Future. Mayo Clinic Proceedings 83:2, pages 169-175.
Crossref
Crossref
Jason Rice, Christian H. Ottensmeier & Freda K. Stevenson. (2008) DNA vaccines: precision tools for activating effective immunity against cancer. Nature Reviews Cancer 8:2, pages 108-120.
Crossref
Crossref
Richard J. Anderson & Joerg Schneider. (2007) Plasmid DNA and viral vector-based vaccines for the treatment of cancer. Vaccine 25, pages B24-B34.
Crossref
Crossref